Jefferies Group’s Cytori Therapeutics Inc Series S Warrant CYTXZ Stock Holding History

Jefferies Group’s Portfolio CYTXZ Stock Details CYTXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-882,000	Closed	-$2K	–	3053
2019 Q1	$2K	Hold	882,000	–	–	﹤0.01%	2271
2018 Q4	$7K	Hold	882,000	–	–	﹤0.01%	2098
2018 Q3	$4K	Hold	882,000	–	–	﹤0.01%	2335
2018 Q2	$26K	Buy	+882,000	New	+$38.1K	﹤0.01%	2232

Other funds holding CYTXZ

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Jefferies Group's CYTXZ Position: Q2 2019 in Review

Jefferies Group sold out of Cytori Therapeutics Inc Series S Warrant (CYTXZ) in Q2 2019, closing a stake of 882,000 shares — an estimated $2K sold.

Jefferies Group first reported a position in CYTXZ in Q2 2018 and held it in 4 quarters. The position peaked at $26K in Q2 2018. 5 funds tracked by Wall St. Rank hold CYTXZ as of Q2 2019.

Jefferies Group reported no remaining Cytori Therapeutics Inc Series S Warrant position as of Q2 2019 after selling out during the quarter.
Jefferies Group sold 882,000 Cytori Therapeutics Inc Series S Warrant shares in Q2 2019, an estimated $2K.
Jefferies Group first reported a position in Cytori Therapeutics Inc Series S Warrant in Q2 2018 and held it in 4 quarters.
Jefferies Group's Cytori Therapeutics Inc Series S Warrant position peaked at $26K in Q2 2018.
5 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Series S Warrant as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.